About us

Powerful insights - powered by you.

Inagene Diagnostics believes that informed decisions can lead to better outcomes. Our Personalized Insights™ Report gives consumers even greater and more precise control over their health and well-being.

Board of Directors

Don Wright

Chairman and Director


Don Wright brings decades of informatics and healthcare leadership to Inagene Diagnostics. Don is currently the President and CEO of Clarigent Health. Prior to Clarigent, he spent the past decade as Founder growing Assurex Health from technology invented at Mayo Clinic and Cincinnati Children’s Hospital Medical Center to a company of over 500 employees serving almost one million people with mental health conditions. After raising over $86MM in private equity, Assurex was acquired in 2016 by Myriad Genetics for $225MM - plus an additional $175MM in performance-based incentives. The large and successful exit was subsequently honored with Venture Ohio's Exit of the Year award.

Don has served as vice president of product development at Attachmate, leading a 450-person worldwide product development organization. Don has also served as CTO for Spotlight Solutions, a leading provider of retail pricing and revenue optimization products, as well as working on the merger with ProfitLogic, which was sold to Oracle. Don also served as vice president and CIO for Domin-8 Enterprise Solutions, overseeing web-based product offerings, which grew to over six million units under management. Before Assurex, Don was co-founder and CTO of SaaS Capital, a specialty finance company serving the SaaS software market. Don is now using his more than 25 years of experience to assist others turning their ideas into hyper-growth companies.

Alan Greenberg

Co-Founder and Director


Alan is the founder of Minett Capital and co-founder and Chairman of GreenSoil Investments, with a portfolio of venture capital funds focused on investing in companies that enable smart and efficient utilization of resources in two distinct verticals — food/ag tech and real estate tech. He is also the co-founder of Your Music Memory, a world class, unique, iconic, rock 'n roll memorabilia collection focusing on the art of the album cover.

Alan spent almost 30 years in progressively senior positions within his family business, the Minto Group of Companies (www.minto.com), a real estate development business across Canada and in Florida. Until mid-2011, Alan was President and COO of MintoUrban Communities Inc., which focused on residential high-rise condominium development in urban Toronto and residential rentals in Canada. Alan recently retired from all his remaining responsibilities at Minto. In 2016, Alan co-founded City Club Apartments LLC. City Club Apartments is actively developing, owning and managing apartment rentals throughout the MidWest US. More recently, Alan founded Streamliner Properties, which is actively investing in value-add real estate properties in the Greater Toronto Area.

Alan holds a Bachelor of Commerce & Economics from the University of Toronto, sits on the Board of Directors of The Association for Soldiers of Israel as well as Save a Childs Heart. He is a Director Emeritus of the Siminovitch Prize, and sits on the following corporate boards: BridgeGreen Capital (Canada), BioHarvest Inc (Israel), Goby Inc (USA), Electric IQ (USA), Haldor Inc. (Israel) and Inagene Diagnostics (Canada).

Katherine Siminovitch

Co-Founder, Director and Chief Science Advisor


Katherine Siminovitch, M.D., FRCP(C), FRSC, ABIM, a Professor at the University of Toronto and a Senior Investigator at Lunenfeld-Tanenbaum Research Institute and Senior Scientist, Toronto General Hospital Research Institute, founded and directs the MSH/UHN Clinical Genomics Centre (CGC). The CGC provides high throughput genotyping and sequencing services and has undertaken over 10,000 individual genetic analyses providing worldwide service for over 15 years. Dr. Siminovitch directs the Litwin Centre for Genetic Medicine, a provincial centre of excellence for provision of clinical genetics care, providing more than 1,000 reports of genetic results each year.

In 2005, Dr. Siminovitch was awarded the Canadian Society for Clinical Investigation/Royal College of Physicians and Surgeon of Canada Henry Friesen Research Award. Some of her previous honors include the University of Toronto Dales Award for Medical Research and Institute of Medical Sciences Mel Silverman Mentorship Award, the American College of Rheumatology Henry Kunkel Young Investigator Award and, in 1993, election to the American Society of Clinical Investigation. Dr. Siminovitch was awarded a Canada Research Chair in Immunogenomics (2005) and has received a CIHR Senior Scientist Award (2000-2005), an Arthritis Society of Canada Research Scientist Award (1992-2001), an Ontario Ministry of Health Cancer Scientist Award (1986-1996) and the Canadian Life and Health Association Medical Scholarship (1986-1992).

Dr. Siminovitch provides scientific leadership and oversight ensuring that Inagene Diagnostics' genetic testing and recommendations are based on the highest level of stringency and reliability in the industry.

Gideon Soesman

Director


Gideon Soesman is co-founder of GreenSoil Investments, a group of venture capital funds that funds companies with transformative technologies that change how we use the world’s resources. Before co-founding GreenSoil, Gideon founded and managed GMS Capital, a boutique investment bank. At GMS Capital, Gideon worked with several companies on their global business development strategy, helped companies raise funds and managed several mergers and acquisitions for European, American and Israeli companies.

Before GMS Capital, Gideon was responsible for all global merger and acquisition activities for a major division of Royal Philips Electronics. While acting as Senior Director of Corporate Mergers & Acquisitions, Gideon managed deals valued at over $1.5B. At Philips, Gideon also served as Director of Corporate Strategy & Venturing, with overall responsibility for all deal flow management, due diligence, deal negotiations, and portfolio management in Israel.

Prior to joining Philips, Gideon held senior positions at Shaldor and Ergo, both leading strategic management consulting firms in Israel and served as a project manager at MATI, the Centre for Entrepreneurship Development. Gideon holds a B.A. in Economics from the Hebrew University, Jerusalem, and an M.A. in Business Administration from the Boston University / Ben-Gurion University of the Negev. He immigrated to Israel from the Netherlands in 1990.

Nancy White

Director and Chief Executive Officer


Nancy White took on Inagene’s commercial leadership as its Vice President, Marketing and Sales in January 2019. She is a strategic leader with a proven track record in sales, marketing, operations and strategy in the health care, technology and government sectors. Nancy has more than 20 years of commercial and operational experience in bringing oncology, specialty and primary care treatments to doctors and patients. Throughout her career she has mobilized and managed sales and marketing for more than 25 health care brands pre-launch, launch, and lifecycle management through to loss of exclusivity (LOE). She has won a number of marketing awards and held roles of increasing responsibility and scope. Nancy has held a number of senior executive level roles in the pharmaceutical industry and has worked at Novartis Pharmaceuticals, Novartis Oncology, Allergan and Eli Lilly; she has worked in Canada, the United States, and Latin America. She holds a Bachelor of Commerce.

Leadership Team

Nancy White

Chief Executive Officer


Nancy White took on Inagene’s commercial leadership as its Vice President, Marketing and Sales in January 2019. She is a strategic leader with a proven track record in sales, marketing, operations and strategy in the health care, technology and government sectors. Nancy has more than 20 years of commercial and operational experience in bringing oncology, specialty and primary care treatments to doctors and patients. Throughout her career she has mobilized and managed sales and marketing for more than 25 health care brands pre-launch, launch, and lifecycle management through to loss of exclusivity (LOE). She has won a number of marketing awards and held roles of increasing responsibility and scope. Nancy has held a number of senior executive level roles in the pharmaceutical industry and has worked at Novartis Pharmaceuticals, Novartis Oncology, Allergan and Eli Lilly; she has worked in Canada, the United States, and Latin America. She holds a Bachelor of Commerce.

Joseph Elliot

Chief Operating Officer


Dr. Elliot is a hands-on manager with skills and experience in all facets of the biopharmaceutical business including raising capital, financing, licensing, team building, drug development, manufacturing, regulatory affairs (FDA, Health Canada and BfArM). For the past 29 years Joe has been a serial entrepreneur and former venture capitalist. He has broad experience in pharmaceuticals, biologicals and vaccines in the fields of oncology and infectious diseases. Joe has raised over $30 million for a number of companies in which he played a leading executive management role including Receptor Therapeutics Inc., LymphoSign Inc. MDS Proteomics Inc., Exogen Neurosciences Inc., PhageTech Inc. and Cytochroma Inc. Prior to becoming an entrepreneur, Joe held senior technical and international marketing positions with Pharmacia Canada Inc. and Connaught Laboratories Inc. Joe received his PhD in Medical Sciences from McMaster University.

Katherine Siminovitch

Chief Science Advisor


Katherine Siminovitch, M.D., FRCP(C), FRSC, ABIM, is an acclaimed leader in genomic medicine. She has been the driving force behind the development of Inagene into Canada’s scientifically leading pharmacogenetic testing company. Dr. Siminovitch holds the Canada Research Chair in the Mechanisms Regulating Immunologic Disease, the Sherman Family Research Chair in Genomic Medicine, is a Professor at the University of Toronto, a Senior Investigator at Lunenfeld-Tanenbaum Research Institute and Senior Scientist, Toronto General Hospital Research Institute. She founded and directs the MSH/UHN Clinical Genomics Centre, a facility that provides high throughput genotyping and sequencing services, and the Litwin Centre for Genetic Medicine, a provincial centre of excellence for provision of clinical genetics care. Dr. Siminovitch provides scientific leadership and oversight ensuring that Inagene Diagnostics’ genetic testing and recommendations are based on the highest level of stringency and reliability in the industry.

Jeff Albin

Chief Financial Officer


Jeff Albin, CA, CPA, CFP, BBM, took on responsibilities as the Chief Financial Officer (CFO) for Inagene Diagnostics in 2018. Jeff is also the CFO of Minett Capital since 2016 and Vice President of Stockton & Bush, a position he has held since 1996. Jeff handles all finance, accounting, tax, insurance and treasury matters for Inagene. Before joining Stockton & Bush, he was the Assistant Director, Corporate Investments for Greenpark Homes. He received his C.A. while he was with Price Waterhouse.

W. Michael Wilson

Corporate Secretary


Michael Wilson took on responsibilities of Corporate Secretary for Inagene in 2018. Michael is also Executive Vice-President of Minett Capital Inc. He oversees and manages a diverse range of investments and shareholder assets, including private equity funds, real estate assets together with a real estate development business, and a portfolio of investments across a range of sectors. Prior to his current role, Michael founded a consulting business focusing on strategy, growth initiatives, and performance improvement in the asset management and investor services sectors; his clients included large management consulting firms in both North America and Europe.

Michael has also held senior leadership roles in several financial institutions. He has acted as Global Head, Strategy and Transformation, of RBC Investor and Treasury Services; Senior Vice-President, Strategic Initiatives, at RBC; and Head of Strategy and Corporate Services and Head of Reinsurance during the formation of RBC Insurance. Before these, he was Vice-President, Corporate Planning, Quality, and Development for MetLife in Canada. Michael began his career as a lawyer in private practice in Ottawa, where he focused on corporate-commercial law.

Michael was called to the Bar of Ontario in 1986. He holds a BA (Hons.), MA, and LLB from Queen’s University at Kingston, Ontario.

Benjamin D. Pinder

Scientific Director


Dr. Pinder joined the Inagene Diagnostics team in 2018 as its Scientific Director and Manager of Lab Operations. Ben has extensive experience in health care and genomics and has publications in RNA-binding and post-transcription regulation. He has experience in overseeing the next-generation sequencing group at MSH/UHN Clinical Genomics Center where he develops technology that underpins personalized healthcare. Ben is also a Research Associate with the University Health Network and has worked as an Associate Scientist with Affinium Pharmaceuticals.

Ben obtained his PhD in from the University of Toronto’s Department of Biochemistry and Developmental Biology where he investigated mechanisms of post-transcriptional regulation. Ben's postdoctoral work focused on genetic determinants of heritable diseases and drug responsiveness at Mount Sinai. Ben also has a degree in Molecular Biology and Genetics from the University of Guelph.

Lab Certification

Powerful insights - powered by you.

Your genetic analysis is performed in our Toronto laboratory. We have applied for certification by CLIA —the Clinical Laboratory Improvement Amendments of 1988. The objective of the CLIA program is to ensure quality laboratory testing. A CLIA-certified lab must meet certain quality standards, including qualifications for individuals who perform the test and other standards that ensure the accuracy and reliability of results.

We use leading technology to check your genetics. The MassARRAY® System by Agena Bioscience combines mass spectrometry, sensitive and robust chemistry, and advanced data analysis software.

Inagene holds a Medical Device Establishment License #9922 from Health Canada.

Contact us

If you have questions or need further information, please feel free to send us an email to
customerservice@inagene.com

Inagene Diagnostics Inc.
802-2345 Yonge St., Toronto ON M4P 2E5